Novo Says Sales Will Drop as US Pushes for Lower Drug Prices
Novo Nordisk A/S said its sales will drop this year as its blockbusters Ozempic and Wegovy face ever-tougher competition and the company gets hit by the US government’s push to...
By Naomi Kresge · Bloomberg
Novo Nordisk A/S said its sales will drop this year as its blockbusters Ozempic and Wegovy face ever-tougher competition and the company gets hit by the US government’s push to cut drug prices.